Jefferies Group LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Sep 21, 2023	SELL	$25.68 - $35.59 $1.28 Million - $1.77 Million	-49,700 Reduced 99.4%	300 $10,000
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $2,568 - $3,559	100 Added 50.0%	300 $10,000
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $1.24 Million - $2 Million	-49,800 Reduced 99.6%	200 $6,000
Q2 2021 Sep 21, 2023	BUY	$32.46 - $43.42 $1.62 Million - $2.17 Million	50,000 New	50,000 $1.75 Million
Q2 2021 Aug 20, 2021	SELL	$32.46 - $43.42 $161 Million - $215 Million	-4,950,000 Reduced 99.0%	50,000 $1.75 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $160 Million - $214 Million	4,933,000 Added 7362.69%	5,000,000 $1.75 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $1.36 Million - $2.29 Million	-28,000 Reduced 29.47%	67,000 $4.23 Million
Q3 2019 Nov 13, 2019	SELL	$45.35 - $57.91 $1.42 Million - $1.82 Million	-31,400 Reduced 24.84%	95,000 $4.61 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $3.95 Million - $4.75 Million	75,000 Added 145.91%	126,400 $6.65 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $751,812 - $1.01 Million	-18,800 Reduced 26.78%	51,400 $2.72 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $4.69 Million - $6.94 Million	-148,600 Reduced 67.92%	70,200 $2.88 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $1.88 Million - $2.53 Million	-49,500 Reduced 18.45%	218,800 $8.31 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $10.4 Million - $13.5 Million	268,300 New	268,300 $12.1 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.